Panamera Holdings Corp (PHCI)
1.31
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Panamera Holdings Net Income (Quarterly): -7.509M for April 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
April 30, 2024 | -7.509M |
January 31, 2024 | -0.0416M |
October 31, 2023 | -0.063M |
July 31, 2023 | -7.099M |
April 30, 2023 | -0.0092M |
January 31, 2023 | -0.0124M |
October 31, 2022 | -0.0042M |
July 31, 2022 | -0.0048M |
April 30, 2022 | -0.0201M |
January 31, 2022 | -0.0066M |
October 31, 2021 | -0.0025M |
July 31, 2021 | -0.0705M |
April 30, 2021 | -0.0066M |
January 31, 2021 | -0.0061M |
October 31, 2020 | -0.0121M |
July 31, 2020 | -0.0062M |
April 30, 2020 | -0.0065M |
January 31, 2020 | -0.0058M |
October 31, 2019 | -0.0126M |
Date | Value |
---|---|
July 31, 2019 | -0.0062M |
April 30, 2019 | -0.0054M |
January 31, 2019 | -0.0066M |
October 31, 2018 | -0.0121M |
July 31, 2018 | -0.0051M |
April 30, 2018 | -0.0059M |
January 31, 2018 | -0.0065M |
October 31, 2017 | -0.0128M |
July 31, 2017 | -0.006M |
April 30, 2017 | -0.0052M |
January 31, 2017 | -0.0074M |
October 31, 2016 | -0.0089M |
July 31, 2016 | -0.0126M |
April 30, 2016 | -0.0223M |
January 31, 2016 | -0.0083M |
October 31, 2015 | -0.014M |
July 31, 2015 | -0.0358M |
April 30, 2015 | -0.0076M |
January 31, 2015 | -0.0075M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-7.509M
Minimum
Apr 2024
-0.0025M
Maximum
Oct 2021
-0.827M
Average
-0.0079M
Median
Net Income (Quarterly) Benchmarks
R1 RCM Inc | -19.90M |
TruBridge Inc | -5.049M |
PetMed Express Inc | 2.326M |
LENZ Therapeutics Inc | -10.22M |
Oruka Therapeutics Inc | -- |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 7.509M |
EPS Diluted (Quarterly) | -0.17 |
Enterprise Value | 59.56M |
Earnings Yield | -28.42% |
Normalized Earnings Yield | -15.46 |